miRNA-203在甲状腺乳头状癌中的表达及其对WRO细胞增殖能力的影响

关善斌; 黄新若; 李加伟; 黄天斌

doi:10.13201/j.issn.1001-1781.2016.22.006

miRNA-203在甲状腺乳头状癌中的表达及其对WRO细胞增殖能力的影响

- 1 梧州市红十字会医院普通外科二区(广西梧州, 543002);
- 2 梧州职业学院

详细信息

通讯作者: 关善斌,E-mail:869379986@qq.com

中图分类号: R736.1

收稿日期: 2016-09-10

Investigate the expression of miRNA-203 in papillary thyroid carcinomaand its effect on cell proliferation

- 1 Department of General Surgery, the Red Cross Hospital of Wuzhou, Wuzhou, 543002, China;
- 2 Vocational Institute of Wuzhou

More Information

Corresponding author: GUAN Shanbin, E-mail: 869379986@qq.com

Received Date: 10 September 2016

摘要

摘要: 目的:研究miRNA-203在甲状腺乳头状癌组织中的表达水平及其与癌组织临床病理参数的相关性,并探讨其在甲状腺乳头状癌WRO细胞增殖过程中的作用。方法:收集2013-2016年30例甲状腺乳头状癌组织及其配对癌旁组织病理标本,采用荧光定量PCR方法检测甲状腺癌组织和癌旁组织中miRNA-203的表达水平,并分析其与临床病理参数的相关性;同时转染miRNA-203 mimics调控WRO细胞株,用MTT、流式分析和Western blot方法分析WRO细胞的增殖能力、周期改变及相关周期蛋白(CyD1、CyB1)的变化。结果:相对于癌旁组织,甲状腺乳头状癌组织中miRNA-203显著低表达;在WRO细胞中转染miRNA-203 mimics后,可显著抑制细胞增殖能力,阻滞G₂/M期,同时上调CyB1、下调CyD1周期相关蛋白的表达。结论:甲状腺乳头状癌组织中miRNA-203可能起着抑癌作用,与甲状腺乳头状癌细胞的增殖能力相关,可能是甲状腺乳头状癌干预的新靶点之一。
- 甲状腺乳头状癌 /
- 微小RNA-203 /
- 细胞增殖 /
- 细胞周期
Abstract: Objective: To investigate the expression of miRNA-203 in papillary thyroid carcinoma(PTC)tissues and its correlation with clinical pathological parameters,explore its effect on cell proliferation of WRO cell.Method: Thirty cases of PTC tissues, paired normal tissues were collected in our hospital during 2013-2016. The expression of miRNA-203 was determined by qRT-PCR,then the relationship of miRNA-203 expression, clinical pathological parameters were analyzed.WRO cells were transfected with miRNA-203 mimics, then cell proliferation, cell cycle and concerned cyclin protein(CyD1,CyB1) were tested by MTT, flow cytometry and western blot.Result: Compared to the paired normal tissues,tumor tissues showed sifnificantly lower expression of miRNA-203. Upregulaion of miRNA-203 in WRO cells effectively reduced cell growth, G₂/M arrest. Mechanistically, in the miRNA-203-mimics-treated groups, cell-cycle-related proteins cyclin B1 was up-regulated, while cyclin D1 was down-regulated.Conclusion: miRNA-203 may play an anticarcinogenic effect in PTC. Upregulation of miRNA-203 is highly correlated with cell prolliferation, and maybe miRNA-203 is a potential targert for the treatment of thyroid carcinoma.
- thyroid papillary carcinoma /
- miRNA-203 /
- cell proliferation /
- cell cycle

HTML全文

参考文献(22)

[1]	SANTINI J, HADDAD A. Total thyroidectomy is the recommended treatment for all papillary thyroid carcinoma(PTC)[J]. Acta Otorhinolaryngol Belg,1999,53:161-164.
[2]	JIAO L I, TAO Y, TENG Z,et al. Clinical outcome of radioiodine therapy in low-intermediate risk papillary thyroid carcinoma with BRAF(V600E) mutation[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2016,38:346-350.
[3]	WANG J, SUN H, GAO L, et al. Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus:a clinical study of 73 patients[J]. Head Neck,2016,38 Suppl 1:E1510-E1514.
[4]	DANYSH B P, RIEGER E Y, SINHA D K, et al. Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model[J]. Oncotarget,2016,7:30907-30923.
[5]	BARTEL D P. MicroRNAs:genomics, biogenesis, mechanism, and function[J]. Cell,2004,116:281-297.
[6]	FURUTA M, KOZAKI K I, TANAKA S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma[J]. Carcinogenesis,2010,31:766-776.
[7]	HE J H, LI Y M, LI Y G, et al. Hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide[J]. Exp Ther Med,2013,5:1315-1321.
[8]	ZHANG F, YANG Z, CAO M, et al. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer[J]. Cancer Lett,2014,342:121-129.
[9]	BRITO J P, GIONFRIDDO M R, AL N A, et al. The accuracy of thyroid nodule ultrasound to predict thyroid cancer:systematic review and meta-analysis[J]. J Clin Endocrinol Metab,2014,99:1253-1263.
[10]	MOO T A, MCGILL J, ALLENDORF J, et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma[J]. World J Surg, 2010, 34:1187-1191.
[11]	RICHARDSON D S, GUJRAL T S, PENG S, et al. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins[J]. Cancer Res,2009,69:4861-4869.
[12]	GUERRA A, ZEPPA P, BIFULCO M, et al. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma[J]. Thyroid,2014,24:254-259.
[13]	PAL D, MUKHOPADHYAY D, RAMAIAH M J, et al. Regulation of cell proliferation and migration by miR-203 via GAS41/miR-10b Axis in human glioblastoma cells[J]. PLoS One,2016,11:e159092-e159092.
[14]	郭岩,王琳,刘鸣,等. miR-203在肿瘤研究中的进展[J]. 医学综述,2013,23(1):63-65.
[15]	XIANG J, BIAN C, WANG H, et al. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer[J]. J Exp Clin Cancer Res,2015,34:8-12.
[16]	TO K K, LEUNG W W, NG S S. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development[J]. Mol Carcinog,2016,[Epub ahead of print].
[17]	BOLDRUP L, COATES P J, WAHLGREN M, et al. Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins[J]. J Carcinog,2012,11:18-21.
[18]	HAILER A, GRUNEWALD T G, ORTH M, et al. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1(LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration[J]. Oncotarget,2014,5:4144-4153.
[19]	REN Z G, DONG S X, HAN P, et al. miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer[J]. Oncol Rep,2016,35:1365-1374.
[20]	LI J, CHEN Y, ZHAO J, et al. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression[J]. Cancer Lett,2011,304:52-59.
[21]	QU Y, LI W C, HELLEM M R, et al. MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells[J]. Int J Cancer,2013,133:544-555.
[22]	XU M, GU M, ZHANG K, et al. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2[J]. Diagn Pathol,2015,10:24-25.